BE776769A - PHARMACEUTICAL COMPOSITION - Google Patents

PHARMACEUTICAL COMPOSITION

Info

Publication number
BE776769A
BE776769A BE776769A BE776769A BE776769A BE 776769 A BE776769 A BE 776769A BE 776769 A BE776769 A BE 776769A BE 776769 A BE776769 A BE 776769A BE 776769 A BE776769 A BE 776769A
Authority
BE
Belgium
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BE776769A
Other languages
French (fr)
Inventor
H J F Adams
B H Takman
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of BE776769A publication Critical patent/BE776769A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
BE776769A 1971-01-26 1971-12-16 PHARMACEUTICAL COMPOSITION BE776769A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10994271A 1971-01-26 1971-01-26

Publications (1)

Publication Number Publication Date
BE776769A true BE776769A (en) 1972-06-16

Family

ID=22330411

Family Applications (2)

Application Number Title Priority Date Filing Date
BE776768A BE776768A (en) 1971-01-26 1971-12-16 PHARMACEUTICAL COMPOSITION
BE776769A BE776769A (en) 1971-01-26 1971-12-16 PHARMACEUTICAL COMPOSITION

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BE776768A BE776768A (en) 1971-01-26 1971-12-16 PHARMACEUTICAL COMPOSITION

Country Status (18)

Country Link
AT (2) AT310938B (en)
AU (1) AU465875B2 (en)
BE (2) BE776768A (en)
BR (2) BR7108428D0 (en)
CA (2) CA983850A (en)
DD (2) DD96144A5 (en)
DE (2) DE2163054C3 (en)
DK (2) DK130389B (en)
ES (2) ES398108A1 (en)
FR (2) FR2123278B1 (en)
GB (1) GB1370904A (en)
HU (2) HU162185B (en)
IE (2) IE35937B1 (en)
LU (1) LU64664A1 (en)
NL (2) NL7117401A (en)
NO (2) NO135891C (en)
SE (2) SE391127B (en)
ZA (2) ZA718326B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998051290A3 (en) * 1997-05-16 1999-02-11 Childrens Medical Center Local anesthetic formulations comprising a site 1 sodium channel blocker combined with a second active agent
US8952152B2 (en) 2009-03-24 2015-02-10 Proteus S.A. Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
US8975268B2 (en) 2013-03-15 2015-03-10 The Children's Medical Center Corporation Neosaxitoxin combination formulations for prolonged local anesthesia

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917894A (en) * 1988-06-29 1990-04-17 Beecham Inc. Rapid-onset long-duration oral anesthetic composition
US6030974A (en) * 1997-04-02 2000-02-29 The Regents Of The University Of California Method of anesthesia
WO2007110221A1 (en) 2006-03-27 2007-10-04 Wex Pharmaceuticals Inc. Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998051290A3 (en) * 1997-05-16 1999-02-11 Childrens Medical Center Local anesthetic formulations comprising a site 1 sodium channel blocker combined with a second active agent
US6326020B1 (en) 1997-05-16 2001-12-04 Children's Medical Center Corporation Local anesthetic formulations
US8952152B2 (en) 2009-03-24 2015-02-10 Proteus S.A. Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
US8957207B2 (en) 2009-03-24 2015-02-17 Proteus S.A. Methods for producing phycotoxins
US9249150B2 (en) 2009-03-24 2016-02-02 Proteus S.A. Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
US8975268B2 (en) 2013-03-15 2015-03-10 The Children's Medical Center Corporation Neosaxitoxin combination formulations for prolonged local anesthesia
US8975281B2 (en) 2013-03-15 2015-03-10 The Children's Medical Center Corporation Neosaxitoxin combination formulations for prolonged local anesthesia
US10314833B2 (en) 2013-03-15 2019-06-11 The Children's Medical Center Corporation Neosaxitoxin combination formulations for prolonged local anesthesia
US10881647B2 (en) 2013-03-15 2021-01-05 The Children's Medical Center Corporation Neosaxitoxin combination formulations for prolonged local anesthesia

Also Published As

Publication number Publication date
IE35910B1 (en) 1976-06-23
BR7108428D0 (en) 1973-06-14
IE35937L (en) 1972-07-26
FR2123278B1 (en) 1975-08-01
DE2163054C3 (en) 1979-02-01
LU64664A1 (en) 1972-08-23
ZA718326B (en) 1972-09-27
SE391127B (en) 1977-02-07
FR2123277A1 (en) 1972-09-08
AU465875B2 (en) 1975-10-09
BR7108429D0 (en) 1973-06-14
ZA718327B (en) 1972-09-27
FR2123277B1 (en) 1975-06-13
DK131606C (en) 1976-01-12
BE776768A (en) 1972-06-16
DE2163054B2 (en) 1978-06-01
GB1370904A (en) 1974-10-16
SE391286B (en) 1977-02-14
NL7117404A (en) 1972-07-28
DD96144A5 (en) 1973-03-12
AT310939B (en) 1973-10-25
AU3710171A (en) 1973-06-28
CA986012A (en) 1976-03-23
AT310938B (en) 1973-10-25
DK130389B (en) 1975-02-17
NO135891B (en) 1977-03-14
DE2163054A1 (en) 1974-05-02
IE35910L (en) 1972-07-26
DE2163055A1 (en) 1972-10-12
HU162185B (en) 1973-01-29
ES398109A1 (en) 1975-03-16
HU162347B (en) 1973-02-28
AU3710071A (en) 1973-06-28
DK131606B (en) 1975-08-11
ES398108A1 (en) 1975-03-01
CA983850A (en) 1976-02-17
DK130389C (en) 1975-07-14
DD96400A5 (en) 1973-03-20
FR2123278A1 (en) 1972-09-08
NL7117401A (en) 1972-07-28
NO135892B (en) 1977-03-14
NO135891C (en) 1978-05-16
NO135892C (en) 1978-05-16
IE35937B1 (en) 1976-07-07

Similar Documents

Publication Publication Date Title
FI56487B (en) REQUIREMENTS FOR FRAMSTAELLNING AV EN LAETT FLUIDISERBAR INHALERBAR PHARMACEUTICAL COMPOSITION
BE817126A (en) FIBRINOLYTIC PHARMACEUTICAL COMPOSITION
BE789950A (en) PHOTOPOLYMERISABLE COMPOSITION
RO77018A (en) PYTOTOXIC COMPOSITION
BE768269A (en) PHARMACEUTICAL COMPOSITION
CH545223A (en) Bottle harass
CH540643A (en) Pesticide composition
BE793266A (en) PHOTOPOLYMERISABLE COMPOSITION
FR2287223A1 (en) PHARMACEUTICAL COMPOSITION
IE35991L (en) Camphor-containing pharmaceutical composition
BE782981A (en) PHARMACEUTICAL COMPOSITIONS
DK143912C (en) DOSAGE UNIT
SE398198B (en) PHARMACEUTICAL DEVICE
IT966335B (en) DISINFESTANT COMPOSITION
FR2290196A1 (en) PHARMACEUTICAL COMPOSITION
BE775640A (en) PHARMACEUTICAL COMPOSITION
IT1050203B (en) ANTI-BREATHING COMPOSITION
BE789658A (en) POLYURETHANE-TAR COMPOSITIONS
BE782444A (en) PHARMACEUTICAL COMPOSITIONS
BE776769A (en) PHARMACEUTICAL COMPOSITION
FR2100950A1 (en) PHARMACEUTICAL COMPOSITION
BE775619A (en) ANESTHESIC COMPOSITIONS
TR18524A (en) FUNGISOXIC SUBSTANCES
BE779323A (en) HEMOSTATIC PREPARATION
SE400275B (en) EXPLOSIVE COMPOSITION